Article
Steroid receptor coactivator-3 as a potential molecular target for cancer therapy
27 Aug 2012
Abstract excerpt
INTRODUCTION: Steroid receptor coactivator-3 (SRC-3), also called amplified-in-breast cancer-1 (AIB1), is an oncogenic coactivator in endocrine and non-endocrine cancers. Functional studies demonstrate SRC-3 promotes numerous aspects of cancer, through its capacity as a coactivator for nuclear hormone receptors and other transcription factors, and via its ability to control multiple growth pathways...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
